In breast cancer, overexpression of h-prune has been demonstrated to be involved in cancer progression, identifying subsets of patients with higher tumour aggressiveness (although it seems to have no role as independent prognostic factor in clinical outcome of patients with invasive breast carcinoma) [30]. Here, PRUNE1 is linked to neoplasm.